| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/08/2007 | WO2007027421A2 Method for diagnosing non-small cell lung carcinoma |
| 03/08/2007 | WO2007027353A2 Detection of proteases secreted from pathogenic microorganisms |
| 03/08/2007 | WO2007027234A2 Enzyme detection technique |
| 03/08/2007 | WO2007027231A1 Diagnostic test kits with improved detection accuracy |
| 03/08/2007 | WO2007027210A2 Multi-functional and configurable assays |
| 03/08/2007 | WO2007027198A1 Nitrite detection technique |
| 03/08/2007 | WO2007027159A1 Water-soluble fluorescent particle comprising entangled fluorescent polymer and amphiphilic molecule |
| 03/08/2007 | WO2007027157A1 Method of deriving progenitor cell line |
| 03/08/2007 | WO2007027099A1 Cell for testing fluids at elevated pressures |
| 03/08/2007 | WO2007027075A1 Use of peptide ihsmnstil of the l1 protein of hpv16 for the diagnosis and prevention of infection with the human papillomavirus |
| 03/08/2007 | WO2007026972A2 Binding protein molecule |
| 03/08/2007 | WO2007026969A1 Drug target protein and target gene, and screening method |
| 03/08/2007 | WO2007026926A1 NOVEL 16S rRNA METHYLASE GENE, PROTEIN PRODUCED FROM THE GENE, AND METHOD FOR DETECTION OF THE GENE OR PROTEIN |
| 03/08/2007 | WO2007026896A1 Composition and method for diagnosing kidney cancer and estimating kidney cancer patient’s prognosis |
| 03/08/2007 | WO2007026895A1 Kit and method for detection of urothelial cancer |
| 03/08/2007 | WO2007026874A1 Method for screening of substance effective on disease using gpr120 and phospholipase |
| 03/08/2007 | WO2007026823A1 Detection of target nucleic acid based on the formation of triplex nucleic acid using artificial nucleic acid probe |
| 03/08/2007 | WO2007026814A1 Test tool |
| 03/08/2007 | WO2007026808A1 Novel fluorescent labeling compound |
| 03/08/2007 | WO2007026773A1 Medical diagnosis processor |
| 03/08/2007 | WO2007026731A1 Biochip and immunological analysis method |
| 03/08/2007 | WO2007026669A1 Method for determination of recognition specificity of virus for receptor sugar chain |
| 03/08/2007 | WO2007026567A1 ANALGESIC AGENT COMPRISING p75NTR INHIBITOR AS ACTIVE INGREDIENT |
| 03/08/2007 | WO2007026408A1 Stable labeling medium usable in biological experiments |
| 03/08/2007 | WO2007026325A1 Confocal raman spectroscopy for dermatological studies |
| 03/08/2007 | WO2007026246A2 Synapse-specific proteins in glomeruli |
| 03/08/2007 | WO2007026214A1 Predicting responses to drugs or drug candidates |
| 03/08/2007 | WO2007026177A1 Gas-sensing semiconductor devices |
| 03/08/2007 | WO2007026171A2 Vdcc gamma-8 ion channel |
| 03/08/2007 | WO2007026152A1 Electrochemical sensor |
| 03/08/2007 | WO2007026143A1 Tensile tester |
| 03/08/2007 | WO2007026140A2 Use of a labelled marker for determinating the kidney function |
| 03/08/2007 | WO2007026099A2 Method of examining a biological process using a fret measurement |
| 03/08/2007 | WO2007026061A1 Method for quantifying a cholinergic neurotoxin in a sample |
| 03/08/2007 | WO2007025999A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 03/08/2007 | WO2007025964A1 Method for detecting a biochemical interaction |
| 03/08/2007 | WO2007025768A1 Optically fluorescent nanoparticles |
| 03/08/2007 | WO2007025672A1 Device for calibration of a humidity sensor and a sensor arrangement with a humidity sensor which may be calibrated |
| 03/08/2007 | WO2007025559A1 Coagulation test system |
| 03/08/2007 | WO2007025558A1 Analyte test system using non-enzymatic analyte recognition elements |
| 03/08/2007 | WO2007025390A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | WO2007025385A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 03/08/2007 | WO2007025366A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 03/08/2007 | WO2007025348A1 An isotope ratio mass spectrometer and methods for determining isotope ratios |
| 03/08/2007 | WO2007011389A9 Method and apparatus for enhanced nano-spectroscopic scanning |
| 03/08/2007 | WO2007008073A3 METHODS FOR DETERMINING THE EFFECT OF A TREATMENT ON THE CROSS-ß STRUCTURE CONTENT OF A PROTEIN; SELECTION OF TREATMENTS AND USES THEREOF |
| 03/08/2007 | WO2007001438A3 Functionalized fluorescent nanocrystals, and methods for their preparation and use |
| 03/08/2007 | WO2006137009A3 Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents |
| 03/08/2007 | WO2006136990A3 Cartridge, system and method for automated medical diagnostics |
| 03/08/2007 | WO2006134546A3 Accurate magnetic biosensor |
| 03/08/2007 | WO2006134518A3 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices |
| 03/08/2007 | WO2006133192A3 Generation and use of a catalog of polypeptide-related information for chemical analyses |
| 03/08/2007 | WO2006133171A3 Biosensor strips and methods of preparing same |
| 03/08/2007 | WO2006133103A3 Reservoir for delivery of agents |
| 03/08/2007 | WO2006125000A3 Method for the production of resveratrol in a recombinant oleaginous microorganism |
| 03/08/2007 | WO2006124827A8 Molecular dissection of cellular responses to alloantigen or autoantigen in graft rejection and autoimmune disease |
| 03/08/2007 | WO2006118615A3 Clonable tag for purification and electron microscopy labeling |
| 03/08/2007 | WO2006116727A3 Compositions and methods for detection of sirolimus |
| 03/08/2007 | WO2006113522A3 Methods of detecting hepatitis c virus |
| 03/08/2007 | WO2006109279A3 Analyte determination method and analyte meter |
| 03/08/2007 | WO2006107962A3 Methods and products for evaluating an immune response to a therapeutic protein |
| 03/08/2007 | WO2006099537A3 The use of antibody-surrogate antigen systems for detection of analytes |
| 03/08/2007 | WO2006096691A9 Determination of folate in samples of serum or plasma |
| 03/08/2007 | WO2006091630A3 Determination of viable microorganisms using coated paramagnetic beads |
| 03/08/2007 | WO2006091412A3 Adamts-7 as a biomarker for cancers of epithelial origin |
| 03/08/2007 | WO2006078581A3 Inactivated pepsin fraction, pharmaceutical compositions, and methods for detecting and treating diseases |
| 03/08/2007 | WO2006073491A3 System and method for producing chemical or biochemical signals |
| 03/08/2007 | WO2006041983A3 Channel current cheminformatics and bioengineering methods for immunological screening, single-molecule analysis, and single-molecular-interaction analysis |
| 03/08/2007 | WO2006038212A3 Methods and compositions for the diagnosis and treatment of cancer |
| 03/08/2007 | WO2006038101A3 Novel cancer associated antibodies and antigens and their use in cancer diagnosis |
| 03/08/2007 | WO2006014816A3 Canis sphingosine 1-phosphate receptor isoform 2 |
| 03/08/2007 | WO2005123966A3 Compositions and methods for diagnosis and treatment of orthopoxviruses |
| 03/08/2007 | WO2005084369A3 Arrays of colloidal crystals |
| 03/08/2007 | WO2005076013B1 Process for screening glycoform-specific antibodies |
| 03/08/2007 | WO2005039393A3 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 03/08/2007 | WO2004076643A3 CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 03/08/2007 | US20070056049 p53 and VEGF regulate tumor growth of NOS2 expressing cancer cells |
| 03/08/2007 | US20070055486 Disease simulation system and method |
| 03/08/2007 | US20070055459 Structure-based approach to design of protein-processivity factor interactions |
| 03/08/2007 | US20070055453 Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
| 03/08/2007 | US20070055448 Primary rat hepatocyte toxicity modeling |
| 03/08/2007 | US20070055438 Method and apparatus for analysing particulates |
| 03/08/2007 | US20070055174 Method and apparatus for penetrating tissue |
| 03/08/2007 | US20070055056 251 human secreted proteins |
| 03/08/2007 | US20070055050 Methods and reagents for diagnosis and treatment of diabetes |
| 03/08/2007 | US20070054961 Factor |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054861 Therapeutic uses of SMR1 peptides |
| 03/08/2007 | US20070054859 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation |
| 03/08/2007 | US20070054850 Screening method |
| 03/08/2007 | US20070054849 Method for diagnosing hepatocellular carcinomas |
| 03/08/2007 | US20070054848 Composition and method for nerve regeneration |
| 03/08/2007 | US20070054846 Bcl-w structure and uses therefor |
| 03/08/2007 | US20070054418 molecularly imprinted material comprising pores or channels having surfaces that include a plurality of molecularly imprinted cavities wherein the material comprises a polysilsesquioxane polymer |
| 03/08/2007 | US20070054417 Method and device for the detection of very small quantities of particles |
| 03/08/2007 | US20070054416 High density sample holder for analysis of biological samples |
| 03/08/2007 | US20070054415 assay for utilizing attenuated total reflection in which a sensing surface in a flow channel can be washed sufficiently and rapidly; surface plasmon resonance |
| 03/08/2007 | US20070054414 Apparatus comprising sample pad,test strips and visual indicators with enhanced shelf life for use in monitoring oral, blood-based, spinal, environmental and chemical fluids; point of care testing |